Clarity Pharmaceuticals Rises as Prostate Cancer Trial Meets Enrollment Target
Clarity Pharmaceuticals shares climbed after its prostate cancer trial met its enrollment target.
Clarity Pharmaceuticals shares climbed after its prostate cancer trial met its enrollment target.